ABSTRACT. Ovarian cancer is currently the most lethal gynecological malignancy in women. It is a heterogeneous and cytogenetically complex disease previously associated with genomic instability. Our purpose was to analyze microsatellite markers to determine patterns and levels of instability as well as possible correlations with histopathological parameters. Polymerase chain reaction was used to characterize microsatellite instability (MSI) and loss of heterozygosity (LOH) in 24 ovarian tumors at 12 microsatellite loci. A total of 11 samples displayed MSI or LOH. Only low-level MSI was found. Markers D5S346 and CYP11 showed the highest MSI and LOH frequencies. D17S250 LOH was significantly associated with tumor histological type (P = 0.0003), and estrogen receptor α was also associated with tumor histological type (P = 0.048) when a combined analysis of LOH and MSI was performed. Furthermore, LOH was observed in a greater number of markers compared with those displaying MSI. Thus, our results support that MSI is less common than LOH in ovarian cancers.
INTRODUCTION
Ovarian cancer is currently the most lethal gynecological malignancy in women despite its low prevalence. Because this cancer is especially difficult to diagnosis and is often detected late, it has a small chance of cure. Approximately 75% of ovarian cancers are diagnosed at advanced stages, at which overall patient survival is usually <30% (Huan et al., 2008; Inca, 2012) .
Ovarian cancer is the 8th most common malignancy in women worldwide, affecting approximately 225,500 women and causing almost 140,200 cancer deaths per year (Jemal et al., 2011) . This cancer is the 4th most frequent cause of cancer-related death in women in Europe and the United States (Bandiera et al., 2012) . In Brazil, 5530 women were diagnosed with ovarian cancer in 2008, and 2982 women died from the disease (Ferlay et al., 2010) . According to data from Instituto Nacional de Câncer (Brazilian National Cancer Institute), 6190 and 110 new cases of ovarian cancer are expected in Brazil and Espírito Santo State, respectively, in 2012 (Instituto Nacional de Câncer José Alencar Gomes da Silva, 2011).
The molecular pathogenesis of ovarian cancer is still poorly understood (Shen et al., 2006) ; however, it is believed that microsatellite instability (MSI) or loss of heterozygosity (LOH) at various chromosomal locations is implicated (Plisiecka-Hałasa et al., 2008) . MSI is defined as a size change in short tandem repeat sequences in a tumor compared with normal tissue from the same patient (Boland et al., 1998) . It was first described in colorectal cancers and it has since been shown to play a significant role in several other cancers. The association of MSI and cancer has advanced the detection of cancer susceptibility, chemotherapy response, and prognosis (Sood et al., 2001 ). MSI at numerous loci in multiple cancers suggests that genetic instability is an important event in the progression of cancer (Galindo et al., 2011) . In ovarian tumors, the reported incidence of MSI ranges from 5 to 50% depending on the markers and definition of MSI used (Sood et al., 2001) .
LOH results from the random loss of 1 allele through deletion or gene conversion, leading to a putative tumor growth advantage (Ando et al., 2000; Powierska-Czarny et al., 2003) . LOH is of particular importance because it enables recessive variants (especially in tumor suppressor genes) to influence tumor phenotype. High LOH frequency regions are candidates for harboring tumor suppressor genes (Skirnisdottir et al., 2012) . In ovarian carcinoma, LOH is a common phenomenon, but some regions have high LOH frequencies without responsible candidate genes (Plisiecka-Hałasa et al., 2008) . In the present study, we analyzed MSI and LOH in 24 ovarian carcinomas at 12 microsatellite loci to identify possible correlations between these events and histopathological tumor features. 
MATERIAL AND METHODS

Ethics
Sample collection and DNA preparation
Archival formalin-fixed, paraffin-embedded tissues from 24 ovarian cancer samples were obtained from the Department of Pathology of Santa Rita de Cássia Hospital, ES, Brazil, during 2009 and 2010. Tumor samples were collected by pathologist-guided, 3-mm punches of tumor blocks. Briefly, histology slides were prepared from formalin-fixed, paraffin-embedded tissues, stained with hematoxylin/eosin, and allowed to air dry. Tumor tissue was marked in hematoxylin/eosin-stained slides by the pathologist and aligned with the respective sample block so that the punch could be taken. Normal tissue control was also obtained from each block.
DNA extraction
DNA was obtained from 0.5-mm punch slices through incubation at 58°C for 5 days in 0.5 M Tris, 0.02 M ethylenediaminetetraacetic acid, 0.01 M NaCl, 1 mg/mL proteinase K, and 2% sodium dodecyl sulfate and subsequent organic extraction with phenol-chloroform. Finally, samples were eluted in 100 µL 3 mM Tris-HCl, pH 7.5 and 0.2 mM ethylenediaminetetraacetic acid-sodium hydroxide, pH 8.0.
Microsatellite analysis
Twelve markers [CYP19, CYP11, androgen receptor (AR), D8S135, D10S197, UGT1A1, D2S119, D3S1611, estrogen receptor (ER) α, ERβ, D5S346, and D17S250] were used in this study for MSI and LOH analysis. Polymerase chain reaction was performed in simplex reactions with a final volume of 15 µL using cycling conditions specific to each primer pair. Polymerase chain reaction was performed using Taq Platinum ® enzyme (Invitrogen, Carlsbad, CA, USA) according to manufacturer recommendations. Amplified fragments were resolved on 15% polyacrylamide gels at 160 V for 15 h and visualized after silver staining. MSI was detected when tumor alleles showed size contraction or expansion compared with normal tissue alleles. LOH was defined as a visible reduction of 50% or more in the normal band intensity. LOH was only detectable when normal alleles were heterozygous. Positive cases were reamplified for confirmation.
Statistical analysis
Statistical tests were performed using SPSS version 17.0 and Epi-Info version 3.5.1. Associations between MSI/LOH and tumor clinicopathological parameters were determined using the Fisher exact test and odds ratio with 95% confidence intervals (95%CIs). A significance value of P < 0.05 was used for all analyses.
RESULTS
DNA samples from 24 ovarian tumors and their adjacent normal tissue were analyzed using 12 short tandem repeat markers. Patients had a mean age of 55 years and a median of 54.5 years, ranging from 30 to 84 years (standard deviation, 13.8 years). Tumor samples consisted of 7 serous cystoadenocarcinoma (29.2%), 1 mucinous cystoadenocarcinoma (4.2%), 7 other malignant tumors (29.2%), 5 metastatic ovarian tumors (20.8%), and 4 borderline tumors (16.6%).
Genomic instability analysis
Eleven of 24 ovarian tumors presented MSI or LOH. The highest MSI frequency was for marker D5S346, being 2.4% the average MSI frequency for all markers (range: 0-13.6%). CYP11 showed the highest LOH frequency, being 6.2% the average LOH frequency for all markers (range: 0-15.4%).
Considering positivity at only 1 locus, frequencies of 16.7 and 25% were found for MSI and LOH, respectively (MSI: 4/24, 95%CI = 1.78-31.62%; LOH: 6/24, 95%CI = 7.68-42.32%). Considering positivity at 2 loci, frequencies of MSI and LOH were both 4.17% (1/24, 95%CI = 0.00-11.97%). At 3 or more loci, MSI frequency dropped to 0% (0/24), whereas LOH frequency was 4.17% (1/24, 95%CI = 0.00-11.97%).
Genomic instability characteristics, number of heterozygous loci, and the total number of samples analyzed for each marker are listed in Table 1 . Genomic instability results by case are presented in Table 2 . Tumor case AR CYP11 CYP19 D8S135 D10S197 UGT1A1 D2S119 D3S1611 ERa ERβ D5S346 D17S250
Open dots = LOH; filled dots = MSI; x = non-informative. 
Correlation between MSI/LOH and clinicopathological parameters
We observed no statistically significant correlations between MSI/LOH and age at diagnosis. However, a significant correlation was observed between D17S250 LOH and mucinous cystoadenocarcinoma (P = 0.0003). Furthermore, a combined analysis of LOH and MSI in ERα showed an association with serous and mucinous cystoadenocarcinomas (P = 0.048).
Marker combination analysis
To increase the efficiency of individual marker analysis, we examined markers in combinations and their possible correlation with ovarian cancer characteristics. Markers were selected according to their genomic instability frequencies -AR/ERα, D5S346/D17S250, and AR/ERα/D5S346/D17S250 -but we found no significant associations between marker group genomic instability and age at diagnosis or histological type (P > 0.05).
DISCUSSION
Ovarian cancer is a heterogeneous and cytogenetically complex disease (Helleman et al., 2006; Skirnisdottir et al., 2012) , exhibiting extensive molecular heterogeneity and several genetic alterations (Darcy and Birrer, 2010) , such as MSI and LOH, which may be related to cancer development (Plisiecka-Hałasa et al., 2008) . We analyzed 24 ovarian tumor samples by using 12 microsatellite markers. Six MSI cases were detected in ERα, D5S346, and D17S250 markers. Our results showed only low-level MSI, defined as instability at <30-40% of loci when more than 5 markers are used (Kuligina et al., 2007) , suggesting that this type of MSI is an event more frequent than high-level MSI (instability at ≥30-40% of loci) in ovarian cancer (Kuligina et al., 2007) . In accordance with our results, data reported by Sood et al. (2001) also showed that low-level MSI is more frequent than high-level MSI in a study of 109 ovarian tumors.
In agreement with the results of previous reports, LOH was more frequent than MSI in ovarian cancer (Allen et al., 2000; Bozzetti et al., 2004; Plisiecka-Hałasa et al., 2008) , being detected in 7 markers (AR, CYP11, D10S197, D3S1611, ERα, D5S346, and D17S250) and in 8 ovarian cancer samples (33.3%). However, some samples showed LOH in more than 1 locus simultaneously.
D17S250 LOH was correlated with tumor histological type. This marker is used in hereditary non-polyposis colorectal cancer syndrome, which is associated with ovarian cancer. Hereditary non-polyposis colorectal cancer syndrome is the 3rd leading cause of hereditary ovarian cancer (Pal et al., 2008) . Approximately 10 to 15% of hereditary ovarian cancers are found in patients with this syndrome (Aysal et al., 2012) . However, D17S250 is centromeric to the breast cancer 1 gene, which is a tumor suppressor gene; therefore, breast cancer 1 or other genes on chromosome 17q may be involved in ovarian cancer carcinogenesis. LOH on chromosome 17q has been previously associated with the development of ovarian cancer in elderly patients, especially high-grade serous or mixed endometrioid-serous carcinomas (Garcia et al., 2000) .
In conclusion, we observed that MSI and LOH frequencies varied among the studied markers. Nevertheless, LOH was observed in a greater number of markers than those displaying MSI. Our data support that LOH is a more frequent event than MSI in ovarian cancer.
